CA2091253A1 - Method for inhibiting the infectivity of human immunodeficiency virus - Google Patents

Method for inhibiting the infectivity of human immunodeficiency virus

Info

Publication number
CA2091253A1
CA2091253A1 CA002091253A CA2091253A CA2091253A1 CA 2091253 A1 CA2091253 A1 CA 2091253A1 CA 002091253 A CA002091253 A CA 002091253A CA 2091253 A CA2091253 A CA 2091253A CA 2091253 A1 CA2091253 A1 CA 2091253A1
Authority
CA
Canada
Prior art keywords
gpl20
antibodies
lymphocytes
hiv
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002091253A
Other languages
English (en)
French (fr)
Inventor
Franco Celada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
New York University Langone Orthopedic Hospital
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2091253A1 publication Critical patent/CA2091253A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1145—Env proteins, e.g. gp41, gp110/120, gp160, V3, principal neutralising domain [PND] or CD4-binding site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2812—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA002091253A 1990-09-28 1991-08-26 Method for inhibiting the infectivity of human immunodeficiency virus Abandoned CA2091253A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58972290A 1990-09-28 1990-09-28
US589,722 1990-09-28

Publications (1)

Publication Number Publication Date
CA2091253A1 true CA2091253A1 (en) 1992-03-29

Family

ID=24359218

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002091253A Abandoned CA2091253A1 (en) 1990-09-28 1991-08-26 Method for inhibiting the infectivity of human immunodeficiency virus

Country Status (4)

Country Link
EP (1) EP0550516A1 (enExample)
AU (1) AU653366B2 (enExample)
CA (1) CA2091253A1 (enExample)
WO (1) WO1992005799A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69227112D1 (de) * 1991-07-16 1998-10-29 Transmed Biotech Inc Verfahren und zusammensetzungen für die gleichzeitige analyse einer vielzahl von analyten
AU6080794A (en) * 1992-12-31 1994-08-15 Ramot University Authority For Applied Research And Industrial Development Ltd. Antibodies directed against binding-associated epitopes
DK0699077T3 (da) * 1993-05-07 2002-01-21 Bio Merieux Inc Immunogele HIV-komplekser
AU3196895A (en) * 1994-07-19 1996-02-16 Beth Israel Hospital Antibodies that bind a conformationally altered CD4 molecule induced upon human immunodeficiency virus binding
EP0903860A1 (en) 1997-09-17 1999-03-24 Matsushita Electric Industrial Co., Ltd. PLL frequency synthesizer
AU2221600A (en) 1998-12-31 2000-07-31 Chiron Corporation Improved expression of hiv polypeptides and production of virus-like particles
ATE384795T1 (de) 1998-12-31 2008-02-15 Novartis Vaccines & Diagnostic Modifizierte hiv env polypeptide
EP1141314A2 (en) 1998-12-31 2001-10-10 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
US6908612B2 (en) 1999-10-08 2005-06-21 University Of Maryland Biotechnology Institute Virus coat protein/receptor chimeras and methods of use
US7311920B1 (en) 1999-10-08 2007-12-25 University Of Maryland Biotechnology Institute Virus coat protein/receptor chimeras and methods of use
AU7862500A (en) * 1999-10-08 2001-04-23 University Of Maryland Biotechnology Institute Virus coat protein/receptor chimeras and methods of use
FR2799974B1 (fr) * 1999-10-25 2001-11-30 Aventis Pasteur Complexe deglycosyle proteine env/cd4 et son utilisation pour la vaccination contre le vih
AU2002320314A1 (en) 2001-07-05 2003-01-21 Chiron, Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
US20030170614A1 (en) 2001-08-31 2003-09-11 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2591227B1 (fr) * 1985-12-06 1988-11-10 Pasteur Institut Peptides capables d'inhiber les interactions entre les virus lav et les lymphocytes t4, produits qui en sont derives et leurs applications
CA1339857C (en) * 1987-05-29 1998-05-05 Cecily Rou-Yun Sun Monoclonal antibodies to gp120 which neutraleze hiv-1
US4908203A (en) * 1987-09-09 1990-03-13 Johnson & Johnson Method for inducing HIV neutralizing antibodies using an internal image idiotope

Also Published As

Publication number Publication date
EP0550516A4 (enExample) 1994-04-06
WO1992005799A1 (en) 1992-04-16
AU653366B2 (en) 1994-09-29
AU8631791A (en) 1992-04-28
EP0550516A1 (en) 1993-07-14

Similar Documents

Publication Publication Date Title
Celada et al. Antibody raised against soluble CD4-rgp120 complex recognizes the CD4 moiety and blocks membrane fusion without inhibiting CD4-gp120 binding.
Chanh et al. Monoclonal anti-idiotypic antibody mimics the CD4 receptor and binds human immunodeficiency virus.
US6057421A (en) Variable heavy and light chain regions of murine monoclonal antibody 1F7
AU653926B2 (en) HIV-1 ENV fragment fusion protein
US5854400A (en) Monoclonal antibodies which neutralize HIV-1 infection
NZ228869A (en) Hiv peptides, antibodies and vaccines
HK110594A (en) Antibody heteroconjugates for the killing of hiv-infected cells
AU653366B2 (en) Method for inhibiting the infectivity of human immunodeficiency virus
CA2066607A1 (en) Peptides associated with the cd4 binding region of gp120 and their methods of use
EP0492560B1 (en) Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of HIV-1, and related peptides
EP0366718A1 (en) HIV-1 NEUTRALIZING MONOCLONAL ANTIBODIES.
US6008044A (en) Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of human immunodeficiency virus-1 (HIV-1) and detection of antibodies against epitope (GCSGKLIC)
US5516895A (en) Antibodies specific towards gp 48
WO1993023427A1 (en) Hiv protein epitopes immunologically homologous to hla
WO1992015885A1 (en) Methods for selecting antibody reagents; anti-idiotype antibodies; and aids vaccine formulations
IE920785A1 (en) Methods for selecting antibody reagents; anti-idiotype¹antibodies; and aids vaccine formulations
Sugano et al. Human monoclonal antibody against glycoproteins of human immunodeficiency virus
US6083504A (en) Human monoclonal antibodies directed against the transmembrane glycoprotein (GP41) of human immunodeficiency virus-1 (HIV-1)
JP2583555B2 (ja) ヒト免疫不全ウイルス（ｈｉｖ）の検出と治療のための方法および物質
WO1989010416A1 (en) PROTECTIVE PEPTIDES DERIVED FROM HUMAN IMMUNODEFICIENCY VIRUS-1 gp160
JP4423374B2 (ja) Ｈｉｖ−２型ヒトレトロウイルスのトランスメンブランエンベロープ糖タンパク質の抗原、及び、該抗原に免疫類似性を有する抗原
KR920001772B1 (ko) 포유류 중의 HIV-억제 항체 유도성 사람 면역 결핍 바이러스(HIV) env-암호화된 펩타이드
EP0512023A1 (en) Medicaments and methods for treating aids and arc employing anti-carbohydrate antibodies and carbohydrate antigens
JP2007534615A (ja) Ｈｉｖ免疫原性複合体
EP0717847B1 (en) Use of antibodies against beta-2 microglobulin-free, class i hla molecules to provide hiv diagnostic tests as well as compositions having a protective action against hiv infections

Legal Events

Date Code Title Description
FZDE Discontinued